Target Name: MIR4775
NCBI ID: G100616361
Review Report on MIR4775 Target / Biomarker Content of Review Report on MIR4775 Target / Biomarker
MIR4775
Other Name(s): hsa-miR-4775 | MicroRNA 4775 | hsa-mir-4775 | microRNA 4775

MIR4775: A Potential Drug Target and Biomarker

MIR4775 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is miR-4775, and it is a microRNA (miRNA) that was identified as a potential drug target and biomarker.

miR-4775 is a non-coding RNA molecule that is around 200 nucleotides long. It is made by the microRNA gene family, which is a group of RNA molecules that are involved in regulating gene expression. miR-4775 is expressed in various tissues of the body and is highly conserved across different species, which suggests that it is an ancient gene that has been preserved over time.

One of the unique features of miR-4775 is its expression pattern. It is mainly expressed in the brain, heart, and kidneys, and its levels are significantly higher in these tissues compared to other tissues. This suggests that miR-4775 may be involved in the regulation of important cellular processes in these tissues, including cell growth, differentiation, and survival.

Another potential drug target for miR-4775 is its role in cell signaling. miR-4775 has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway. TGF-β is a well-known signaling pathway that is involved in cell growth, differentiation, and survival, while the Wnt pathway is involved in the regulation of cell growth and differentiation.

In addition to its potential drug target properties, miR-4775 has also been shown to be a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This is because its expression is often altered in these diseases, and these changes can be used as biomarkers for the development and progression of these diseases.

One of the potential applications of miR-4775 as a drug target is its ability to target multiple downstream signaling pathways. This is because miR-4775 has been shown to interact with multiple proteins, including TGF-β, Wnt, and NF-kappa-B. This creates a complex network of interactions that can be targeted by drugs, which can lead to improved treatment outcomes.

Another potential application of miR-4775 as a drug target is its role in the regulation of cellular processes that are important for maintaining tissue homeostasis. This is because miR-4775 has been shown to be involved in the regulation of several processes that are important for maintaining tissue structure and function, including cell adhesion, migration, and angiogenesis. Targeting miR-4775 with drugs that can modulate its activity may have therapeutic applications in diseases that are characterized by disruptions in these processes, such as cancer and neurodegenerative diseases.

In conclusion, miR-4775 is a protein that has the potential to be a drug target and biomarker. Its expression pattern and interactions with other proteins make it an attractive target for drugs that can modulate its activity. Further research is needed to fully understand the role of miR-4775 in cellular processes and its potential therapeutic applications.

Protein Name: MicroRNA 4775

The "MIR4775 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4775 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2